Skip to main content

Advertisement

Table 1 Baseline characteristics of the participants.

From: Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects

  Ezetimibe n = 24 Simvastatin n = 25 p-value
Women (%) 79 76  
Caucasians (%) 41 47  
Smoking (%) 4 12  
Hypertension (%) 92 80  
Age (years) 53.4 ± 9.3 53.1 ± 8.1 0.893
Body mass index (kg/m2) 33.1 ± 4.5 31.9 ± 3.4 0.333
Systolic blood pressure (mmHg) 129.3 ± 16.2 124.0 ± 20.4 0.325
Diastolic blood pressure (mmHg) 83.3 ± 8.7 81.6 ± 11.5 0.575
Total cholesterol (mg/dL) 237.4 ± 43.2 214.4 ± 39.7 0.058
LDL-cholesterol (mg/dL) 145.9 ± 39.9 129.4 ± 36.8 0.139
HDL-cholesterol (mg/dL) 56.1 ± 13.7 53.1 ± 11.5 0.408
Triglycerides (mg/dL) 176.8 ± 85.4 160.0 ± 65.5 0.443
Fasting plasma glucose (mg/dL) 104.3 ± 6.7 110.0 ± 11.7 0.041
  1. Data are expressed in number of subjects or mean ± standard deviation.